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Huntington disease (HD) is an inherited neurodegenerative disorder characterized 
by degeneration of neurons affecting initially the striatum and progressively the cortex. 
Clinical symptoms include motor and cognitive alterations leading inevitably to 
death. The disease involves expansion of CAG trinucleotide repeats in the huntingtin 
gene codifying for glutamines in the htt protein. We performed a proteomic analysis 
of human brain post-mortem samples obtained from striatum and cortex of patients 
with HD compared to samples of age and sex-matched controls. Antioxidant defense 
proteins that were strongly induced in striatum, but also detectable in cortex, were 
identified as peroxiredoxins 1, 2 and 6, as well as glutathione peroxidases 1 and 6. The 
activities of other antioxidant enzymes such as mitochondrial superoxide dismutase 
and catalase were also increased in HD. Aconitase, a protein involved in energy 
metabolism, showed decreased activities in striatum of HD patients. Protein carbonyls, 
used as markers of oxidative stress, were increased in HD and glial fibrillary acidic 
protein was identified as the main target. Moreover,  other proteins such us aconitase, 
γ-enolase and creatine kinase were also found oxidized in HD. Taken together, these 
results indicate that oxidative stress and damage to specific macromolecules, would 
participate in the disease progression from striatum to cortex. Also, these data support 
the rationale for therapeutic strategies that either potentiate antioxidant defenses or 
avoid oxidative stress generation in order to delay disease progression.
